We also tested for other possible mechanisms that may be responsible for decreasing the levels of GSH in individuals with T2DM such as free radicals production in response to inflammatory cytokines (IL-6 and IL-17). This evidence concerns the gene IL17A and type 2 diabetes mellitus.